Riociguat: A Novel New Drug for Treatment of Pulmonary Hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Riociguat: A Novel New Drug for Treatment of Pulmonary Hypertension

Published:2015-05 Issue:5 Volume:35 Page:502-519
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Makowski Charles T.¹,Rissmiller Richard W.²,Bullington Wendy M.³

Affiliation:

1. Department of Pharmacy Services; Henry Ford Hospital; Detroit Michigan

2. Division of Pulmonary and Critical Care; Medical University of South Carolina; Charleston South Carolina

3. Department of Pharmacy Services; Medical University of South Carolina; Charleston South Carolina

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/phar.1592/fullpdf

Reference64 articles.

1. Pulmonary arterial hypertension in France: results from a national registry;Humbert;Am J Respir Crit Care Med,2006

2. Survival in pulmonary arterial hypertension: a brief review of registry data;Pauwaa;Pulm Circ,2011

3. Primary pulmonary hypertension: natural history and the importance of thrombosis;Fuster;Circulation,1984

4. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension;Rich;N Engl J Med,1992

5. The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension;Frank;Chest,1997

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelial dysfunction in Sickle Cell Disease: Strategies for the treatment;Nitric Oxide;2024-08

2. A Review of Modern and Traditional Approaches for the Management of Pulmonary Hypertension;Current Traditional Medicine;2023-07-12

3. Long-term outcomes of combined pulmonary endarterectomy and additional balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension;General Thoracic and Cardiovascular Surgery;2022-09-21

4. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension;European Heart Journal;2022-08-26

5. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension;European Respiratory Journal;2022-08-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3